Your browser doesn't support javascript.
loading
Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients.
Contreras-Castillo, Stephania; Plaza, Anita; Stojanova, Jana; Navarro, Gustavo; Carmona, Rodolfo; Corvalán, Fernando; Cerpa, Leslie; Sandoval, Christopher; Muñoz, Daniel; Leiva, Marina; Castañeda, Luis E; Farias, Nayaret; Alvarez, Carolina; Llull, Gabriel; Mezzano, Sergio; Ardiles, Leopoldo; Varela, Nelson; Rodríguez, María S; Flores, Claudio; Cayún, Juan Pablo; Krall, Paola; Quiñones, Luis A.
Afiliação
  • Contreras-Castillo S; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Plaza A; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Stojanova J; Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Valparaíso, Chile.
  • Navarro G; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, NSW, Australia.
  • Carmona R; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Corvalán F; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Cerpa L; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Sandoval C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Muñoz D; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
  • Leiva M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Castañeda LE; Pharmacy Institute, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile.
  • Farias N; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Alvarez C; Program of Human Genetics, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Llull G; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.
  • Mezzano S; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.
  • Ardiles L; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.
  • Varela N; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Rodríguez MS; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
  • Flores C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cayún JP; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
  • Krall P; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.
  • Quiñones LA; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.
Front Pharmacol ; 12: 674117, 2021.
Article em En | MEDLINE | ID: mdl-34938174
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: America do sul / Chile Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: America do sul / Chile Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile País de publicação: Suíça